Page last updated: 2024-10-22

amiodarone and Vocal Cord Paralysis

amiodarone has been researched along with Vocal Cord Paralysis in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Vocal Cord Paralysis: Congenital or acquired paralysis of one or both VOCAL CORDS. This condition is caused by defects in the CENTRAL NERVOUS SYSTEM, the VAGUS NERVE and branches of LARYNGEAL NERVES. Common symptoms are VOICE DISORDERS including HOARSENESS or APHONIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brosch, S1
Johannsen, HS1

Other Studies

1 other study available for amiodarone and Vocal Cord Paralysis

ArticleYear
[Medication-induced vocal cord paralysis as an uncommon cause of cord paralysis].
    HNO, 1999, Volume: 47, Issue:9

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Follow-Up Studies; Humans; Laryngoscopy; Ma

1999